With a plethora of news stories on the global financial meltdown, we wondered if we’d hear anything different from the pharma industry leaders we contacted for our story. Not surprisingly, the tone reflected industry sentiment, with a few nuggets of gold coming in. But what took us by surprise was the return phone calls from the some sources, who called to check on the story, to get a fix on what the ‘others’ had said and also the slant of our story. The point is, as it turns out, they need not have worried. The brave front is very much in place, even after the Mumbai’s bloodbath on November 26 (some of the Express Pharma team members had to spend that night in office, across the road from the ill-fated Oberoi/Trident hotel). While there will be repercussions, like the postponement of CPhI India, and belt-tightening measures, the industry is taking all steps to hunker down and weather out the storm. The fundamentals of the Indian pharma industry remain strong and Express Pharma aims to be a mirror to the industry’s hopes. In a year’s time, we are confident that the meltdown may have cracked certain markets but overall, the Indian pharma industry would have emerged stronger and a winner. After all, we may have to concede a war, to win the fina+l battle.
Regular readers will note that we have introduced a new section in this issue, the Research Review section, devoted to research articles from students related to the life sciences. We hope to repeat such a segment at least once a quarter. As this issue is a Special issue for the 60th Indian Pharmaceutical Congress (IPC) to be held in Delhi, we look forward to a great response from the students and academia at this event, which has become an official think-tank for the who’s who in our industry. What makes this year’s event special, other than it is the Diamond Jubilee year, is the regulatory focus, as it is being held in the nation’s capital. As more Indian pharma companies fall under the regulatory lens of overseas regulators, this year’s sessions will be expected to give direction and clarify many grey areas. Watch out for detailed reports in the issues that follow.